Safety information regarding drug use during pregnancy is insu‹cient. The present study aimed to establish an optimal signal detection method to identify adverse drug reactions in pregnant women and to evaluate information in the Japanese Adverse Drug Event Report (JADER) database between April 2004 and November 2014. We identiˆed reports on pregnant women using the Standardised MedDRA Queries. We calculated the proportional reporting ratio (PRR) and reporting odds ratio (ROR) of the risk factors for the two known risks of antithyroid drugs and methimazole (MMI) embryopathy, and ritodrine and fetal/infant cardiovascular events. The PRR and ROR values diŠered between all reports in the JADER database and those on pregnant women, aŠecting whether signal detection criteria were met. Therefore we considered that reports on pregnant women should be used when risks associated with pregnancy were determined using signal detection. Analyses of MMI embryopathy revealed MMI signals ［PRR, 159.7; ROR, 669.9; 95％ conˆdence interval (CI), 282.4 1588.7] but no propylthiouracil signals (PRR, 1.98; ROR, 2.0; 95％CI, 0.3 15.4). Theseˆndings were consistent with those of reported risks. Analyses of fetal/infant cardiovascular events revealed ritodrine signals (PRR, 2.1; ROR, 2.1; 95％CI, 1.4 3.3). Theseˆndings were also consistent with reported risks. Mining the JADER database was helpful for analyzing adverse drug reactions in pregnant women.
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